CNRS Technologies

Find the best CNRS technologies to boost your innovative project.

Newest patents

You are a research scientist?

We can guide you through the whole technology transfer process.

See all our services

You are a corporate player?

Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.

Contact us

Follow our news and upcoming events

Discover CNRS technologies

Meet our team

Close

Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials

Reference

86958-01

Keywords

Salts, Anions

Patents status

Priority patent of invention CA2194127 filed on Decembre 30, 1996 entitled “Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials”

Inventors

Michel ARMAND
Christophe MICHOT
Michel GAUTHIER
Yves CHOQUETTE

commercial status

Non-exclusive licenses

Laboratory

Laboratoire réactivité et chimie des solides, UMR 6007, Amiens, France, http://www.u-picardie.fr/labo/lrcs/

Description

TECHNICAL DESCRIPTION

The invention concerns ionic compounds in which the anionic load has been delocalized. A compound disclosed by the invention is comprised of an amide or one of its salts, including an anionic portion combined with at least one cationic portion M+m in sufficient numbers to ensure overall electronic neutrality; is the compound is further comprised of M as a hydroxonium, a nitrosonium NO+, an ammonium –NH4+, a metallic cation with the valence m, an organic cation with the valence m, or an organometallic cation with the valence m. The anionic portion matches the formula RF–SOx–N-Z, wherein RF is a perfluorinated group, x is 1 or 2, and Z is an electroattractive substituent.

INDUSTRIAL APPLICATIONS

The compounds can be used notably for ionic conducting materials, electronic conducting materials, colorants, and the catalysis of various chemical reactions.

For further information, please contact us (Ref 86958-01)

Need further information ?

Contact us
Close

Contact us

  • This field is for validation purposes and should be left unchanged.
Close

Newest patents